Pharmaceutical In case anyone missed it, the main news this week was Pfizer and BioNTech announcing that a Phase III trial of their COVID-19 vaccine had shown more than 90% efficacy in a Phase III trial. Eli Lilly also made a major advance in COVID-19, albeit with a treatment rather than a vaccine. Elsewhere, there was analysis of the latest aducanumab update in Alzheimer’s, along with some important data for Amgen and AstraZeneca’s asthma candidate Tezepelumab. 13 November 2020